Physician profile
Jon E Dornacker
NPI 1801804588
$1,112.41
in general payments reported to CMS, 2019-2025
18 companies · $225 in 2025
The $225 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.30 · 2021: $131 · 2022: $159 · 2023: $236 · 2024: $305 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $720 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $720.09 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $280.09 | 2021-2025 | Mounjaro, Zepbound |
| Abbvie INC. | $243.73 | 2021-2025 | |
| Amgen INC. | $114.36 | 2019-2025 | Evenity, Prolia, Prolia |
| Lundbeck LLC | $91.09 | 2023-2024 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $62.87 | 2023-2024 | |
| Exact Sciences Corporation | $50.33 | 2023-2024 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $31.68 | 2021-2025 | Trintellix |
| Biohaven Pharmaceutical Holding Company Ltd. | $31.65 | 2022 | |
| Pfizer INC. | $29.05 | 2023 | |
| Novartis Pharmaceuticals Corporation | $28.99 | 2021 | |
| Ionis Pharmaceuticals, INC. | $25.00 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $22.58 | 2019 | |
| Csl Behring | $20.00 | 2023 | Kcentra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.63 | 2019 | |
| Janssen Pharmaceuticals, INC | $18.36 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $17.63 | 2021 | |
| Astellas Pharma US INC | $13.09 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $12.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Dornacker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.